Collaborators
UK Critical Care Genomics Group
International Severe Acute Respiratory and Emerging Infection Consortium
International Forum for Acute Care Trialists
Guest Lectures
"Personalised Medicine in Sepsis""Cardiovascular Management in Sepsis""New Treatment Strategies for Sepsis", SG-ANZICS - Asia-Pacific Intensive Care Forum, Singapore, 2018
"Biomarkers in sepsis - Improved Phenotyping" "Vasoactive drugs in septic shock - Alternatives to Catecholamines" "How we decide - Why don't all ICUs use selective digestive decontamination (SDD)?", The International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, 2016
Sepsis - How might we improve the outcome?, Swedish Society for Anaesthesiology and Intensive Care, Stockholm, Sweden, 2015
REDUCING THE GLOBAL BURDEN OF SEPSIS: DEVELOPING A ROADMAP. SDD / SOD and prevention of sepsis in the ICU, International Sepsis Forum Colloquium and International Symposium on Intensive Care and Emergency Medicine Roundtable, Brussels, Belgium, 2015
“How should we use vasopressin in septic shock” and “New ICU Clinical Trials for 2015”, Scottish Intensive Care Society, St Andrews, Scotland, 2015
Why don’t we use selective decontamination?, Intensive Care Society “State of the Art Meeting”, London, 2013
New Knowledge in Critical Care – Sepsis, Faculty of Intensive Care Medicine, London, 2013
"Interactions between vasopressin and steroids" and "Biomarkers in sepsis: Metabolic profiles", 33rd International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, 2013
Advances in Sepsis Management, Royal College of Anaesthetists, London, 2013
Outcomes in Critical Care Research, UK Critical Care Research Forum, Belfast, 2012
How should we use vasopressin in septic shock?, UK-China Anaesthesia Summit Forum, Bejing, China, 2012
Genomics from science to clinical practice, Intensive Care Society, State of the Art meeting, London, 2011
Controversies regarding hypothermia and vasopressors, Elisabeth Edén Symposium, Traumatic Brain Injury, Gothenburg, Sweden, 2011
“Sepsis: Controversial therapies – Vasopressin” and “Pro-con debate - Vasopressin before catecholamines in septic shock”, 31st International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, 2011
Septic shock – latest thoughts, Intensive Care Society “State of the Art Meeting”, London, 2010
Can genetic profiles inform clinical management in intensive care?, British Association of Parenteral and Enteral Nutrition annual conference, Harrogate, 2010
Who benefits from Intensive Care? - Cancer and Critical Care Outcomes, Intensive Care Society, Royal College of Anaesthetists, 2009
Vasopressin in Septic Shock, Anglia Ruskin University, 2009
Sepsis Masterclass - Genetics of sepsis, West Midlands Intensive Care Society, Coventry, 2008
Genetic predictors of response to activated protein C, Intensive Care Society “State of the Art Meeting”, London, 2007
“Genetics of activated protein C” and“The effect of vasopressin on renal function in septic shock”, Critical Care Canada Forum, Toronto, 2007
Role of TNF and TNFR polymorphisms in the outcome from severe sepsis & septic shock: lessons from a clinical study, Royal Society of Medicine, 2002
Research Student Supervision
Antcliffe,DB, Metabolic Signatures of Pneumonia in Perioperative and Critical Care: A Paradigm Shift in Diagnosis and Therapeutic Monitoring
Davies,R, Investigating the human inflammatory response in sepsis and sterile injury using an in vitro migration assay to assess monocyte immune function
Komorowski,M, Dynamic mortality prediction and decision support system in the ICU
McLymont,N, Metabolic signatures of sepsis in critical care: an individualised approach to diagnosis and management
O'Callaghan,DD, Mechanisms of monocyte priming and tolerance in vitro and in vivo involving tumour necrosis factor-alpha converting enzyme
Woodbridge,H, When should clinicians start early mobilisation on intensive care? Exploring the barriers to early mobilisation and developing tools to study the safety of mobilisation of Intensive Care Unit patients.